Benchmark Maintains Buy on Imax, Raises Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Mike Hickey maintains a Buy rating on Imax (NYSE:IMAX) and raises the price target from $23 to $24.
October 09, 2023 | 2:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Mike Hickey maintains a Buy rating on Imax and raises the price target from $23 to $24.
The news of a maintained Buy rating and an increased price target by a Benchmark analyst is likely to have a positive impact on Imax's stock price in the short term. Investors often follow analyst recommendations and price targets, which can influence stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100